Assignee
GENEXINE INC
KR18 patents
Top patents by PatentIndex Score
US10208099B2Feb 19, 2019
Modified interleukin-7 protein
GENEXINE INC18 citations90
US7989425B2Aug 2, 2011
Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirus
GENEXINE INC31 citations88
US11041007B2Jun 22, 2021
Modified interleukin-7 protein
GENEXINE INC3 citations69
US10844104B2Nov 24, 2020
Modified interleukin-7 protein
GENEXINE INC4 citations69
US11135262B2Oct 5, 2021
Methods of treating cervical cancer
GENEXINE INC5 citations67
US11548927B2Jan 10, 2023
Formulation of modified interleukin-7 fusion protein
GENEXINE INC2 citations65
US10538569B2Jan 21, 2020
Fusion polypeptide containing GLP and immunoglobulin hybrid Fc and use thereof
GENEXINE INC2 citations64
US12479898B2Nov 25, 2025
Pharmaceutical composition comprising immunoglobulin fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseases
GENEXINE INC0 citations60
US12357677B2Jul 15, 2025
Virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein
GENEXINE INC0 citations60
US11708399B2Jul 25, 2023
Pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseases
GENEXINE INC1 citations60
US11357827B2Jun 14, 2022
Method for preventing or treating influenza virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein
GENEXINE INC1 citations60
US11001620B2May 11, 2021
Composition comprising recombinant human thyroid stimulating hormone and method for producing recombinant human thyroid stimulating hormone
GENEXINE INC0 citations58
US9399665B2Jul 26, 2016
Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer
GENEXINE INC2 citations58
US11883479B2Jan 30, 2024
Method for treating cervical cancer
GENEXINE INC0 citations57
US11524054B2Dec 13, 2022
Method of treating anemia using long-acting EPO formulation
GENEXINE INC0 citations57
US12344647B2Jul 1, 2025
Formulation of modified interleukin-7 fusion protein
GENEXINE INC0 citations55
US12233113B2Feb 25, 2025
Pharmaceutical composition comprising recombinant hGH for the treatment of growth hormone deficiency
GENEXINE INC0 citations53
US12427186B2Sep 30, 2025
Method for treating growth hormone deficiency employing hGH fusion protein
GENEXINE INC0 citations52